0.1.0 - ci-build
SEMedicalAlertInformationImplementationGuide, published by HL7 Sweden. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7Sweden/hl7.fhir.r4.ig.medicalalertinformation/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7.se/fhir/r4/ig/medicalalertinformation/ValueSet/1.2.752.116.3.1.16.1.1 | Version: 0.1.0 | |||
| Draft as of 2026-01-16 | Computable Name: SEAlertInformationOtherMedicalConditionVS | |||
Uppmärksamhetsinformation för annat medicinskt tillstånd.
References
This value set includes codes based on the following rules:
Expansion from tx.fhir.org based on:
This value set contains 87 concepts
| System | Code | Display (en) | JSON | XML |
http://hl7.org/fhir/sid/icd-10 | T78.3 | Angioneurotic oedema | ||
http://hl7.org/fhir/sid/icd-10 | I27.0 | Primary pulmonary hypertension | ||
http://hl7.org/fhir/sid/icd-10 | I27.2 | Other secondary pulmonary hypertension | ||
http://hl7.org/fhir/sid/icd-10 | E27.1 | Primary adrenocortical insufficiency | ||
http://hl7.org/fhir/sid/icd-10 | T88.3 | Malignant hyperthermia due to anaesthesia | ||
http://hl7.org/fhir/sid/icd-10 | D68.0 | Von Willebrand disease | ||
http://hl7.org/fhir/sid/icd-10 | D68.1 | Hereditary factor XI deficiency | ||
http://hl7.org/fhir/sid/icd-10 | D68.2 | Hereditary deficiency of other clotting factors | ||
http://hl7.org/fhir/sid/icd-10 | D68.3 | Haemorrhagic disorder due to circulating anticoagulants | ||
http://hl7.org/fhir/sid/icd-10 | D68.4 | Acquired coagulation factor deficiency | ||
http://hl7.org/fhir/sid/icd-10 | D68.5 | Primary thrombophilia | ||
http://hl7.org/fhir/sid/icd-10 | D68.6 | Other thrombophilia | ||
http://hl7.org/fhir/sid/icd-10 | D68.8 | Other specified coagulation defects | ||
http://hl7.org/fhir/sid/icd-10 | D68.9 | Coagulation defect, unspecified | ||
http://hl7.org/fhir/sid/icd-10 | D69.0 | Allergic purpura | ||
http://hl7.org/fhir/sid/icd-10 | D69.1 | Qualitative platelet defects | ||
http://hl7.org/fhir/sid/icd-10 | D69.3 | Idiopathic thrombocytopenic purpura | ||
http://hl7.org/fhir/sid/icd-10 | D69.4 | Other primary thrombocytopenia | ||
http://hl7.org/fhir/sid/icd-10 | D69.5 | Secondary thrombocytopenia | ||
http://hl7.org/fhir/sid/icd-10 | D69.6 | Thrombocytopenia, unspecified | ||
http://hl7.org/fhir/sid/icd-10 | M31.1 | Thrombotic microangiopathy | ||
http://hl7.org/fhir/sid/icd-10 | G70.0 | Myasthenia gravis | ||
http://hl7.org/fhir/sid/icd-10 | E88.0 | Disorders of plasma-protein metabolism, not elsewhere classified | ||
http://hl7.org/fhir/sid/icd-10 | T88.2 | Shock due to anaesthesia | ||
http://hl7.org/fhir/sid/icd-10 | T88.5 | Other complications of anaesthesia | ||
http://hl7.org/fhir/sid/icd-10 | T88.4 | Failed or difficult intubation | ||
http://hl7.org/fhir/sid/icd-10 | D73.0 | Hyposplenism | ||
http://hl7.org/fhir/sid/icd-10 | Q89.0 | Congenital malformations of spleen | ||
http://hl7.org/fhir/sid/icd-10 | D81 | Combined immunodeficiencies | ||
http://hl7.org/fhir/sid/icd-10 | I77.0 | Arteriovenous fistula, acquired | ||
http://hl7.org/fhir/sid/icd-10 | E71.0 | Maple-syrup-urine disease | ||
http://hl7.org/fhir/sid/icd-10 | E71.2 | Disorder of branched-chain amino-acid metabolism, unspecified | ||
http://hl7.org/fhir/sid/icd-10 | E71.3 | Disorders of fatty-acid metabolism | ||
http://hl7.org/fhir/sid/icd-10 | E72.2 | Disorders of urea cycle metabolism | ||
http://hl7.org/fhir/sid/icd-10 | E72.3 | Disorders of lysine and hydroxylysine metabolism | ||
http://hl7.org/fhir/sid/icd-10 | E74.0 | Glycogen storage disease | ||
http://hl7.org/fhir/sid/icd-10 | E74.1 | Disorders of fructose metabolism | ||
http://hl7.org/fhir/sid/icd-10 | E74.4 | Disorders of pyruvate metabolism and gluconeogenesis | ||
http://hl7.org/fhir/sid/icd-10 | E88.9 | Metabolic disorder, unspecified | ||
http://hl7.org/fhir/sid/icd-10 | E79.8 | Other disorders of purine and pyrimidine metabolism | ||
http://hl7.org/fhir/sid/icd-10 | G71.3 | Mitochondrial myopathy, not elsewhere classified | ||
http://hl7.org/fhir/sid/icd-10 | E25.0 | Congenital adrenogenital disorders associated with enzyme deficiency | ||
http://hl7.org/fhir/sid/icd-10 | K52.2 | Allergic and dietetic gastroenteritis and colitis | ||
http://snomed.info/sct | 41291007 | Angioedema | ||
http://snomed.info/sct | 9651007 | Long QT syndrome | ||
http://snomed.info/sct | 70995007 | Pulmonary hypertension | ||
http://snomed.info/sct | 373662000 | Primary adrenocortical insufficiency (disorder) | ||
http://snomed.info/sct | 405501007 | Malignant hyperthermia | ||
http://snomed.info/sct | 64779008 | Blood coagulation disorder | ||
http://snomed.info/sct | 126729006 | Thrombotic microangiopathy | ||
http://snomed.info/sct | 234467004 | Thrombophilia | ||
http://snomed.info/sct | 91637004 | Myasthenia gravis | ||
http://snomed.info/sct | 234422006 | Acute intermittent porphyria | ||
http://snomed.info/sct | 58275005 | Variegate porphyria | ||
http://snomed.info/sct | 7425008 | Hereditary coproporphyria | ||
http://snomed.info/sct | 64081000 | Porphobilinogen synthase deficiency | ||
http://snomed.info/sct | 360631004 | Deficiency of choline esterase II (unspecific) | ||
http://snomed.info/sct | 33211000 | Complication of anesthesia | ||
http://snomed.info/sct | 718447001 | Difficult intubation | ||
http://snomed.info/sct | 707147002 | Asplenia (disorder) | ||
http://snomed.info/sct | 31323000 | Severe combined immunodeficiency disease | ||
http://snomed.info/sct | 17182001 | Agranulocytosis | ||
http://snomed.info/sct | 770942003 | Severe congenital neutropenia type 3 | ||
http://snomed.info/sct | 89454001 | Shwachman syndrome | ||
http://snomed.info/sct | 439784005 | Surgically constructed arteriovenous fistula (finding) | ||
http://snomed.info/sct | 27718001 | Maple syrup urine disease | ||
http://snomed.info/sct | 116020001 | Disorder of branched-chain amino acid metabolism | ||
http://snomed.info/sct | 39929009 | Disorder of fatty acid metabolism | ||
http://snomed.info/sct | 7046009 | Hyperleucine-isoleucinemia | ||
http://snomed.info/sct | 87827003 | Isovaleryl-CoA dehydrogenase deficiency | ||
http://snomed.info/sct | 42393006 | Methylmalonic acidemia | ||
http://snomed.info/sct | 69080001 | Propionic acidemia | ||
http://snomed.info/sct | 1156591005 | Fatty acid oxidation defect (disorder) | ||
http://snomed.info/sct | 82319005 | Acyl-CoA dehydrogenase deficiency | ||
http://snomed.info/sct | 36444000 | Disorder of the urea cycle metabolism | ||
http://snomed.info/sct | 237929000 | Disorder of lysine and hydroxylysine metabolism | ||
http://snomed.info/sct | 41013004 | Argininosuccinate lyase deficiency | ||
http://snomed.info/sct | 398680004 | Citrullinemia (disorder) | ||
http://snomed.info/sct | 29633007 | Glycogen storage disease | ||
http://snomed.info/sct | 39452003 | Disorder of fructose metabolism | ||
http://snomed.info/sct | 190760009 | Disorders of pyruvate metabolism and gluconeogenesis | ||
http://snomed.info/sct | 75934005 | Metabolic disease | ||
http://snomed.info/sct | 238006008 | Disorder of purine and pyrimidine metabolism | ||
http://snomed.info/sct | 16851005 | Mitochondrial myopathy | ||
http://snomed.info/sct | 237751000 | Congenital adrenal hyperplasia | ||
http://snomed.info/sct | 737315000 | Allergic enterocolitis caused by food protein | ||
http://snomed.info/sct | 439218000 | Surgically constructed arteriovenous graft (finding) |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |